Authors


Somesh C. Nigam, PhD

Latest:

Association of Co-pay Elimination With Medication Adherence and Total Cost

This study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.





Lawrence Blonde, MD, FACP, FACE

Latest:

Achieving Antihyperglycemic Treatment Goals With Incretin-Related Therapies

The management of type 2 diabetes mellitus (T2DM) remains challenging. Limitations associated with many current therapies include hypoglycemia and weight gain. An increased understanding of the pathophysiology of T2DM has led to the development of incretin-related antihyperglycemic therapies.





Jad Hayes, MS, ASA, MAAA

Latest:

Cost Differential by Site of Service for Cancer Patients Receiving Chemotherapy

The cost of care for patients receiving chemotherapy in community oncology clinics is lower than for comparable patients receiving chemotherapy in the hospital outpatient setting.






Moghadameh Mirzaee, PhD

Latest:

Patients' Preferences for Receiving Laboratory Test Results

The main reason given for receiving results online was time savings, reported by 77% of participants, followed by lowering the chance of missing the results (31%).


Edward Kim, MD, MBA

Latest:

Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis

This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.


Warren Stevens, PhD

Latest:

Is the QALY Fit for Purpose?

The quality-adjusted life-year (QALY) is a popular tool for value assessment but is flawed. This paper highlights potential solutions.


Mark Ealovega, MD

Latest:

Ambulatory Care–Sensitive Emergency Visits Among Patients With Medical Home Access

Patients often self-refer to the emergency department (ED) for management of an ambulatory care–sensitive condition, and the ED may be the most appropriate care location.





Weibing Wang, MD, PhD

Latest:

Type 2 Diabetes Mellitus in China: A Preventable Economic Burden

Treatment of type 2 diabetes mellitus and its complications places a heavy burden on healthcare budgets in China and will continue to do so.


Keith D. Bruhnsen, MSW

Latest:

Moving From A to Z: Successful Implementation of a Statin Switch Program by a Large Physician Group

This report shows that a successful, cost-effective statin switch program can be implemented by a large physician group via a centralized, collaborative process.


Jeremy B. Sussman, MD, MS

Latest:

Cardiac Risk Is Not Associated With Hypertension Treatment Intensification

This study shows how cardiovascular prevention would be much more efficient if risk were used in treatment decisions, but that currently it plays no role.




Seth Joseph, MBA

Latest:

A Better Way: Leveraging a Proven and Utilized System for Improving Current Medication Reconciliation Processes

In this reply to the commentary, “A Call for a Statewide Medication Reconciliation Program,” published in the October 2016 issue of The American Journal of Managed Care®, authors discuss a proven and scalable solution to improve medication reconciliation that is already available to, and used by, clinicians.



Lynn L. DeBar, PhD, MPH

Latest:

A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery

This pharmacist-led, patient-directed intervention demonstrated a reduction in opioid dispensings in the 90 days following hip replacement but not knee replacement.



Marsha A. Raebel, PharmD

Latest:

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo